PI3K-AKT-mTOR Pathway Disregulation and its Correlation with Clinical Outcome in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus / Spada, F; Fazio, N; Capurso, G; Panzuto, F; Rinzivillo, M; Pisa, E; Pilozzi, E; Radice, D; Di Rocco, R; Galdy, S; Barucca, V; Barberis, M; Delle Fave, G. - In: PANCREAS. - ISSN 0885-3177. - 43:3(2014), pp. 493-493.
PI3K-AKT-mTOR Pathway Disregulation and its Correlation with Clinical Outcome in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus
Capurso G;
2014-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
